The 39th Conference on Preventive Oncology and Diagnostic Cancer is a leading international scientific meeting scheduled for July 27–28, 2026, in Rome, Italy. The conference is dedicated to advancing research, knowledge exchange, and practical solutions in the areas of cancer prevention, early detection, and diagnostic innovation.
This global forum brings together researchers, clinicians, public health experts, academicians, industry professionals, and policy makers to discuss current challenges and emerging opportunities in preventive oncology. The conference aims to highlight innovative approaches that reduce cancer risk, improve early diagnosis, and enhance patient outcomes through evidence-based strategies and technological advancements.
The scientific program covers a broad spectrum of topics, including cancer epidemiology, biomarkers and screening strategies, precision medicine, molecular and genetic diagnostics, lifestyle and environmental factors in cancer prevention, artificial intelligence in oncology diagnostics, and public health interventions. Through keynote lectures, plenary sessions, oral and poster presentations, participants will engage in meaningful scientific dialogue and interdisciplinary collaboration.
In addition to the academic sessions, the conference provides valuable opportunities for networking, professional development, and collaboration between academia, healthcare institutions, and industry. The historic city of Rome offers an inspiring setting that encourages cultural exchange and informal interaction among participants.
The Preventive Oncology 2026 Conference reflects a shared global commitment to advancing cancer prevention and diagnostic excellence, fostering innovation, and shaping the future of oncology for the benefit of patients and communities worldwide.
